Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TNXP files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTonix Pharmaceuticals reports Q1 2026 operating results
Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read
Key Changes
-
medium
Company announced operating results for the quarter ended March 31, 2026, via press release. Specific financial metrics and performance details are contained in the attached exhibit.
Item 2.02 verify on EDGAR → -
low
This is a routine quarterly earnings disclosure filed under Item 2.02 of Form 8-K. The filing body contains no substantive financial details beyond referencing the press release.
8-K: Earnings view on EDGAR →
Summary
Tonix Pharmaceuticals filed an 8-K to announce its first quarter 2026 operating results for the period ending March 31, 2026. This is a standard quarterly earnings disclosure required under SEC rules. The filing itself is procedural, with the actual financial performance details contained in an attached press release rather than in the body of the 8-K.
For retail investors, this represents routine financial reporting rather than a material corporate event. The key information—revenue, expenses, cash position, and any operational updates—would be found in the press release exhibit. Investors should review that document for specifics on the company's financial health and progress on its pharmaceutical development programs. Watch for any guidance updates or clinical trial milestones mentioned in the full press release.
Section-by-Section Diff
Event · Item 9.01 — Financial Statements and Exhibits
Tonix Pharmaceuticals filed an 8-K attaching a press release dated May 11, 2026; no material business event disclosed in the filing body.
Added in current filing · verify on EDGAR →
Press Release of the Company, dated May 11, 2026
The 8-K references a press release dated May 11, 2026, attached as Exhibit 99.01. The filing body itself contains no substantive disclosure about the press release content or the underlying corporate event. Without access to the exhibit, the nature and materiality of the announcement cannot be determined from this filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify